CIPLA's weekly performance was lackluster, with a return of -0.5% and a Sharpe Ratio of -0.05, indicating poor risk-adjusted returns. The stock's volatility was high at 31.62%, making it a risky investment this week. Compared to its peers, CIPLA outperformed SUNPHARMA and GRASIM but underperformed DIVISLAB. Overall, CIPLA's performance was mediocre, and its high volatility makes it a cautious investment.

[Volatility: 31.62%]